Among these, drug-induced colitis is a rare, but severe side effect, prompting a recent FDA statement regarding this safety concern. Objectives: We analyzed a cohort of ocrelizumab treated patients in ...

One study compared the hospitalization burdens of individuals with diverticulitis and either Crohn’s disease or ulcerative colitis, another form of IBD. It found that the burdens were actually ...

The data to support the use of infliximab in acute severe colitis are less robust than the data for ciclosporin A. Infliximab appears less effective in patients with more severe/fulminant colitis ...

Presented is a middle-aged male who developed a fulminant case of antibiotic-associated pseudomembranous colitis characterized by leukocytosis, hypoalbuminemia, ascites, and anasarca without toxic ...